Loading clinical trials...
Loading clinical trials...
This study is designed to find out how well the COVID-19 vaccine protects people 50 to 64, who don't have any serious health problems, compared to a group that receives a vaccine that doesn't contain ...
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
BioNTech SE
Collaborators
NCT06850350 · Post-acute Sequelae of SARS-CoV-2 Infection
NCT06631287 · Long COVID, Sars-CoV-2 Infection, and more
NCT05101213 · Adenovirus Infection, BK Virus Infection, and more
NCT04565665 · COVID-19 Infection, COVID-19-Associated Acute Respiratory Distress Syndrome, and more
NCT06095297 · Long COVID, Brain Fog, and more
Pinnacle Research Group, LLC
Anniston, Alabama
North Alabama Research Center
Athens, Alabama
Simon Williamson Clinic / Synexus Clinical Research US, Inc.
Birmingham, Alabama
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions